10-QPeriod: Q1 FY2004

INTUITIVE SURGICAL INC Quarterly Report for Q1 Ended Mar 31, 2004

Filed May 7, 2004For Securities:ISRG

Summary

Intuitive Surgical, Inc. (ISRG) reported its first quarter 2004 results, demonstrating significant top-line growth and a return to profitability. Total sales increased by 40% year-over-year to $27.1 million, driven by a substantial 30% increase in product sales and a remarkable 136% surge in service sales. The company achieved a net income of $0.85 million, a significant turnaround from a net loss of $2.3 million in the prior year's first quarter. This improved profitability was supported by a notable expansion in gross margins for both product sales (from 55.1% to 60.8%) and service sales (from 11.4% to 47.5%), reflecting cost efficiencies and leveraging of the growing installed base. The company's balance sheet remains strong, with total assets of $316.3 million and stockholders' equity of $284.2 million. Cash and cash equivalents, along with short-term investments, totaled $115.8 million, indicating solid liquidity. While operating expenses, particularly in research and development, saw an increase due to the integration of acquired products and restructuring activities, the overall financial performance signals positive momentum. Investors should note the ongoing strategic investments in R&D and the potential for continued growth as the company expands its market penetration and product offerings.

Key Highlights

  • 1Total sales grew 40% year-over-year to $27.1 million, driven by strong performance in both product and service segments.
  • 2Net income turned positive, reaching $0.85 million compared to a net loss of $2.3 million in the prior year's quarter.
  • 3Product sales increased by 30% to $22.5 million, fueled by higher instrument, accessory, and system revenues.
  • 4Service sales more than doubled, increasing by 136% to $4.6 million, attributed to a larger installed base and higher average service revenue per site.
  • 5Gross profit margin on product sales improved significantly to 60.8% from 55.1%, driven by cost reductions.
  • 6Gross profit margin on service sales saw a dramatic improvement to 47.5% from 11.4%, reflecting operational leverage.
  • 7The company maintained a strong liquidity position with $115.8 million in cash and short-term investments at quarter-end.

Frequently Asked Questions

The primary driver for the significant increase in sales was growth across both product and service segments. Product sales increased by 30% due to higher instrument, accessory, and system revenues, while service sales surged by 136% driven by a larger installed base of da Vinci Surgical Systems and increased service revenue per site.

While Selling, General, and Administrative expenses increased by 8% and Research & Development expenses rose by 55% (partially due to restructuring charges and integration of acquired products), the company significantly improved its gross margins. Product gross margin improved from 55.1% to 60.8%, and service gross margin expanded dramatically from 11.4% to 47.5%. This improved cost management at the gross profit level, combined with revenue growth, led to a positive net income of $0.85 million, a substantial turnaround from a net loss in the prior year.

Intuitive Surgical maintains a strong financial position. Total assets stood at $316.3 million, with total stockholders' equity at $284.2 million. The company had $115.8 million in cash, cash equivalents, and short-term investments at the end of the quarter, indicating robust liquidity to fund ongoing operations and future growth initiatives.

The company faces risks related to its reliance on a small number of customers for a substantial portion of its revenue, the evolving market acceptance of its technology, regulatory processes (FDA approvals), and potential product liability claims. Commitments include operating lease obligations and ongoing legal proceedings related to acquisitions and past business practices, though a recent significant lease commitment was mitigated by the purchase of the company's main facility on April 30, 2004.